Cargando…
Apoptosis pathways and their therapeutic exploitation in pancreatic cancer
Resistance to apoptosis (programmed cell death) is a characteristic feature of human malignancies including pancreatic cancer, which is one of the leading causes of cancer deaths in the western world. Defects in this intrinsic cell death program can contribute to the multistep process of tumorigenes...
Autor principal: | Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496136/ https://www.ncbi.nlm.nih.gov/pubmed/19382915 http://dx.doi.org/10.1111/j.1582-4934.2009.00748.x |
Ejemplares similares
-
Targeting Apoptosis Signaling in Pancreatic Cancer
por: Fulda, Simone
Publicado: (2011) -
Exploiting inflammation for therapeutic gain in pancreatic cancer
por: Steele, C W, et al.
Publicado: (2013) -
Cell Death Pathways as Therapeutic Targets in Rhabdomyosarcoma
por: Fulda, Simone
Publicado: (2012) -
How to target apoptosis signaling pathways for the treatment of pediatric cancers
por: Fulda, Simone
Publicado: (2013) -
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
por: Fulda, Simone
Publicado: (2012)